Xinhuazhang, an EDA company, announced it has raised a Pre-B+ round to accelerate R&D innovation for next-generation EDA.
This will further solidify Xinhuazhang's leading position in the domestic EDA verification space.
高榕创投
@gaorong
创造美好生活
531 articles
Articles
Gaorong Monthly · December | Gaorong Ventures and Its Frontier Tech / Consumer / Healthcare / Enterprise Service Portfolio Companies Win Multiple Annual Awards
Its technological and innovative capabilities have won recognition.
Hyperparameter Raises $100 Million in Series B Funding to Build Living AI
Dedicated to building out the full "gaming + tech + social" pipeline.
"Tiny but Mighty" miRNA: How Cancer Can Be Caught at Its Earliest Stage | Gaorong Ventures "Future"
By applying microRNA to early cancer screening, we can transform cancer from a terminal illness into a chronic disease that can be intercepted at an early stage.
Hangzhou Andao Pharma Closes $50 Million Series B to Advance Drug Development for Kidney Disease and Cancer
Addressing the enormous unmet clinical needs in nephrology and oncology.
Unknown Closes Nearly $100 Million in Series B Funding, Launches AI×BT Strategy
Focused on gut microbiome AI-driven drug discovery, with self-developed drug candidates already in registrational clinical trials.
Chuanwazi Foods Raises Nearly RMB 300 Million in Series A Funding, Aiming to Become China's Go-To Brand for Fresh Sauce
Bold and zesty, there for every meal.
Chao Wan Zu (潮玩族) Completes Series B Funding Round, Building a Community for Young Collectors
China's largest secondhand designer toy trading platform and community.
When Will We Achieve "Genomic Sequencing Freedom"? | Gaorong Ventures "Future"
A Conversation with the Creator of China's First Mass-Produced Nanopore Gene Sequencer
Rongbao · November | New milestones for drug R&D, chips, and autonomous driving; UJU Media lists on Hong Kong Stock Exchange Main Board
New funding, new products, new applications.